We provide actionable answers from pre-clinical to post-launch. What can Norstella help you with? https://ow.ly/acO550PQWIE #Pipeline2Patient #Answers4Pharma #Pharma Citeline, Evaluate Ltd, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group
Norstella
Information Services
Yardley, PA 42,545 followers
We're on a mission to improve patient access to therapy.
About us
Norstella is a group of prominent pharmaceutical solutions providers – Citeline, Evaluate, MMIT, Panalgo, The Dedham Group – that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient.
- Website
-
http://www.norstella.com
External link for Norstella
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Yardley, PA
- Type
- Privately Held
Locations
-
Primary
Yardley, PA 19067, US
Employees at Norstella
Updates
-
A survey by Citeline and a major contract development and manufacturing organization (CDMO) has uncovered the top reasons why pharma companies are flocking to end-to-end CDMO partnerships. https://ow.ly/VrTl50SxbYH The benefits are game-changing, from cost efficiencies to streamlined processes and tech transfers. The survey also delves into the outsourced functions, including clinical research, manufacturing, and packaging. Click to read the article on how small biopharmas are accelerating the development of their projects with CDMO partnerships. #Pharma #Biopharma #CDMOs
-
-
Norstella reposted this
🤖 How are AI & machine learning transforming pharma forecasting? What's their impact on disease modelling, market sizing, & peak drug share estimates? 👉 Sign up here: https://lnkd.in/gwVCe-_R 🗓 Mark your calendars for Wednesday, 31st July to watch Daniel Chancellor, David James and Stefano Driussi from J+D Forecasting discuss these and other critical questions in our upcoming #webinar.
This content isn’t available here
Access this content and more in the LinkedIn app
-
Due to its increasing global prevalence and significant comorbidities, obesity has become a major focus for drug developers. Download the infographic here: https://ow.ly/nhSJ50S7ho9 Norstella helps stakeholders involved in obesity drug development by providing trusted industry data and expert insights. Our infographic uses those data and insights to assess the complex factors currently impacting obesity research and development, expectations for future developments in this space, and how Norstella can support organizations in delivering life-saving treatments to patients. #Norstella #Pipeline2Patient #Obesity
-
-
Norstella reposted this
Have you tried the all-new Citeline News and Insights app? Access all your favorite award-winning publications, all in one place. Download the app today: https://ow.ly/RsTf50SAi7q. (Available on the App Store and Google Play.)
-
Norstella reposted this
Global Chief Product Officer at Norstella | Guiding product innovation and commercialization from #pipeline2patient
Loved collaborating with Daniel Chancellor and Suzanne Caruso to bring this together. Norstella has long invested in the capabilities of Artificial Intelligence, but with our increasing breadth and unification of data across the drug development and commercialization lifecycle, we are innovating at an ever faster pace. And all of it spells out to be better outcomes for patients. #AI #artificialintelligence #pipeline2patient
As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/JIKt50SxnJ7 Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.
-
-
Norstella held a roundtable discussion in London and we put all the insights from our executive leadership team in one document. Download the "Putting the patient first" report: https://ow.ly/XgFU50SlZsl
-
-
In our blog post, Daniel Chancellor suggests that rather than becoming more risk-averse, drug developers should seek to shift attrition to the earliest stages of development. This allows for prioritization of the best assets with the most significant patient impact. Click to read about why clinical development success rates are falling on the Norstella blog: https://ow.ly/7eIp50RIMsC. #ClinicalDevelopment #DrugDevelopment #Biopharma #BiopharmaceuticalCompanies #BiopharmaTrends
-
Norstella reposted this
Will you be attending the eagerly awaited World Preview #webinar today? You're not going to want to miss it! 👉 Click here to register: https://ow.ly/suy950SztXr 📺 Click here to log into the auditorium: https://ow.ly/eiGm50SztXp
-
-
Norstella reposted this
🌟 Exciting news! 🌟 The annual World Preview #report from Evaluate Ltd is now live. Featuring #pharma forecasts to 2030 and buckets of expert analysis on the data, the report provides fantastic insight into the therapy areas driving growth, the top companies and drugs, market landscape and much more. Download your copy now! https://lnkd.in/gMe5hqD7